Czechia· CZ-0271036
STIRIPENTOL BILLEV
A stiripentol product, registered in Czechia by Billev Pharma Aps, Horsholm. The same ATC class is registered in 17 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Stiripentol is registered in 17 of 19 countries.
Countries holding a registration under ATC N03AX17 (stiripentol), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 9 of them publish a price we can compare per daily dose
Stiripentol · ATC N03AX17
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of stiripentol costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Stiripentol · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$16.74
The record
At a glance
SÚKL (Czech Republic)- Manufacturer
- Billev Pharma Aps, Horsholm
- Country
- Czechia (CZ)
- ATC code
- N03AX17
- ATC class
- Stiripentol
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- July 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
307 interactions on record for stiripentol.
Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Stiripentol · interactions on record
307 records
- 40 severe
- 260 moderate
- 7 minor
Most severe, free to view
- CisaprideA03FA02severe
- NaloxegolA06AH03severe
- EliglustatA16AX10severe
- CilostazolB01AC23severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N03AX17
Stiripentol, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a90709e1-dc2e-4b6f-a4c0-0ccc9c28373e GET /v1/drugs/a90709e1-dc2e-4b6f-a4c0-0ccc9c28373e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "CPS DUR",
"source": "sukl",
"strength": "250MG",
"pack_size": "90",
"substance": "7931",
"cz_kod_sukl": "0271036",
"product_type": "CH",
"registration_state": "R",
"registration_number": "21/529/22-C"
}See everything about stiripentol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.